| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study
|
Wang, Michelle
|
|
|
18 |
4 |
p. 571-583
|
article
|
| 2 |
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors
|
Bauer, Todd M.
|
|
|
18 |
4 |
p. 517-530
|
article
|
| 3 |
Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours
|
Yen, Chih-Chieh
|
|
|
18 |
4 |
p. 611-623
|
article
|
| 4 |
Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis
|
Heseltine, Jonathan
|
|
|
18 |
4 |
p. 593-599
|
article
|
| 5 |
Correction to: Relugolix: A Review in Advanced Prostate Cancer
|
Shirley, Matt
|
|
|
18 |
4 |
p. 637
|
article
|
| 6 |
Cost-Effectiveness Analysis of Biomarker Testing to Guide First-Line PARP Inhibitor Maintenance for Patients with Advanced Ovarian Cancer After Response to First-Line Platinum Chemotherapy in the USA
|
Elsea, David
|
|
|
18 |
4 |
p. 531-541
|
article
|
| 7 |
Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY Study
|
Chiu, Chao-Hua
|
|
|
18 |
4 |
p. 505-515
|
article
|
| 8 |
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
|
Santoni, Matteo
|
|
|
18 |
4 |
p. 559-570
|
article
|
| 9 |
PARP Inhibitors in Ovarian Cancer: A Review
|
O’Malley, David M.
|
|
|
18 |
4 |
p. 471-503
|
article
|
| 10 |
Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer
|
Zheng, Nan
|
|
|
18 |
4 |
p. 625-636
|
article
|
| 11 |
Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study
|
Babey, Hélène
|
|
|
18 |
4 |
p. 585-591
|
article
|
| 12 |
Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer
|
DeMichele, Angela
|
|
|
18 |
4 |
p. 543-558
|
article
|
| 13 |
Role of Underlying Liver Pathology in the Development of Immune-Related Hepatitis: A Case–Control Study
|
Storm, Erica M.
|
|
|
18 |
4 |
p. 601-610
|
article
|
Journal description